Segmental heterogeneity of vasa vasorum neovascularization in human coronary atherosclerosis. 2010

Mario Gössl, and Daniele Versari, and Heike A Hildebrandt, and Thomas Bajanowski, and Giuseppe Sangiorgi, and Raimund Erbel, and Erik L Ritman, and Lilach O Lerman, and Amir Lerman
Division of Cardiovascular Diseases, Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.

OBJECTIVE Our aim was to investigate the role of coronary vasa vasorum (VV) neovascularization in the progression and complications of human coronary atherosclerotic plaques. BACKGROUND Accumulating evidence supports an important role of VV neovascularization in atherogenesis and lesion location determination in coronary artery disease. VV neovascularization can lead to intraplaque hemorrhage, which has been identified as a promoter of plaque progression and complications like plaque rupture. We hypothesized that distinctive patterns of VV neovascularization and associated plaque complications can be found in different stages of human coronary atherosclerosis. METHODS Hearts from 15 patients (age 52+/-5 years, mean+/-SEM) were obtained at autopsy, perfused with Microfil (Flow Tech, Inc., Carver, Massachusetts), and subsequently scanned with micro-computed tomography (CT). The 2-cm segments (n=50) were histologically classified as either normal (n=12), nonstenotic plaque (<50% stenosis, n=18), calcified (n=10) or noncalcified (n=10) stenotic plaque. Micro-CT images were analyzed for VV density (number/mm2), VV vascular area fraction (mm2/mm2), and VV endothelial surface fraction (mm2/mm3). Histological sections were stained for Mallory's (iron), von Kossa (calcium), and glycophorin-A (erythrocyte fragments) as well as endothelial nitric oxide synthase, vascular endothelial growth factor, and tumor necrosis factor-alpha. RESULTS VV density was higher in segments with nonstenotic and noncalcified stenotic plaques as compared with normal segments (3.36+/-0.45, 3.72+/-1.03 vs. 1.16+/-0.21, p<0.01). In calcified stenotic plaques, VV spatial density was lowest (0.95+/-0.21, p<0.05 vs. nonstenotic and noncalcified stenotic plaque). The amount of iron and glycophorin A was significantly higher in nonstenotic and stenotic plaques as compared with normal segments, and correlated with VV density (Kendall-Tau correlation coefficient 0.65 and 0.58, respectively, p<0.01). Moreover, relatively high amounts of iron and glycophorin A were found in calcified plaques. Further immunohistochemical characterization of VV revealed positive staining for endothelial nitric oxide synthase and tumor necrosis factor-alpha but not vascular endothelial growth factor. CONCLUSIONS Our results support a possible role of VV neovascularization, VV rupture, and intraplaque hemorrhage in the progression and complications of human coronary atherosclerosis.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009389 Neovascularization, Pathologic A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions. Angiogenesis, Pathologic,Angiogenesis, Pathological,Neovascularization, Pathological,Pathologic Angiogenesis,Pathologic Neovascularization,Pathological Angiogenesis,Pathological Neovascularization
D002114 Calcinosis Pathologic deposition of calcium salts in tissues. Calcification, Pathologic,Calcinosis, Tumoral,Microcalcification,Microcalcinosis,Pathologic Calcification,Calcinoses,Calcinoses, Tumoral,Microcalcifications,Microcalcinoses,Tumoral Calcinoses,Tumoral Calcinosis
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D005260 Female Females
D006021 Glycophorins The major sialoglycoprotein of human erythrocyte membranes. It consists of at least two sialoglycopeptides and is composed of 60% carbohydrate including sialic acid and 40% protein. It is involved in a number of different biological activities including the binding of MN blood groups, influenza viruses, kidney bean phytohemagglutinin, and wheat germ agglutinin. Erythrocyte Sialoglycoproteins,Glycoconnectin,Glycoconnectins,Glycophorin,Glycophorin D,MN Sialoglycoprotein,Red Blood Cell Membrane Sialoglycoprotein,Glycophorin A,Glycophorin A(M),Glycophorin B,Glycophorin C,Glycophorin E,Glycophorin HA,Ss Erythrocyte Membrane Sialoglycoproteins,Ss Sialoglycoprotein,beta-Sialoglycoprotein,Sialoglycoprotein, MN,Sialoglycoprotein, Ss,Sialoglycoproteins, Erythrocyte,beta Sialoglycoprotein
D006470 Hemorrhage Bleeding or escape of blood from a vessel. Bleeding,Hemorrhages

Related Publications

Mario Gössl, and Daniele Versari, and Heike A Hildebrandt, and Thomas Bajanowski, and Giuseppe Sangiorgi, and Raimund Erbel, and Erik L Ritman, and Lilach O Lerman, and Amir Lerman
January 1985, Perspectives in biology and medicine,
Mario Gössl, and Daniele Versari, and Heike A Hildebrandt, and Thomas Bajanowski, and Giuseppe Sangiorgi, and Raimund Erbel, and Erik L Ritman, and Lilach O Lerman, and Amir Lerman
June 1978, Lancet (London, England),
Mario Gössl, and Daniele Versari, and Heike A Hildebrandt, and Thomas Bajanowski, and Giuseppe Sangiorgi, and Raimund Erbel, and Erik L Ritman, and Lilach O Lerman, and Amir Lerman
April 1998, The Journal of clinical investigation,
Mario Gössl, and Daniele Versari, and Heike A Hildebrandt, and Thomas Bajanowski, and Giuseppe Sangiorgi, and Raimund Erbel, and Erik L Ritman, and Lilach O Lerman, and Amir Lerman
January 1984, The New England journal of medicine,
Mario Gössl, and Daniele Versari, and Heike A Hildebrandt, and Thomas Bajanowski, and Giuseppe Sangiorgi, and Raimund Erbel, and Erik L Ritman, and Lilach O Lerman, and Amir Lerman
January 2015, Journal of atherosclerosis and thrombosis,
Mario Gössl, and Daniele Versari, and Heike A Hildebrandt, and Thomas Bajanowski, and Giuseppe Sangiorgi, and Raimund Erbel, and Erik L Ritman, and Lilach O Lerman, and Amir Lerman
September 2001, Cardiovascular research,
Mario Gössl, and Daniele Versari, and Heike A Hildebrandt, and Thomas Bajanowski, and Giuseppe Sangiorgi, and Raimund Erbel, and Erik L Ritman, and Lilach O Lerman, and Amir Lerman
May 2002, Journal of the American College of Cardiology,
Mario Gössl, and Daniele Versari, and Heike A Hildebrandt, and Thomas Bajanowski, and Giuseppe Sangiorgi, and Raimund Erbel, and Erik L Ritman, and Lilach O Lerman, and Amir Lerman
July 2009, Medical hypotheses,
Mario Gössl, and Daniele Versari, and Heike A Hildebrandt, and Thomas Bajanowski, and Giuseppe Sangiorgi, and Raimund Erbel, and Erik L Ritman, and Lilach O Lerman, and Amir Lerman
April 1989, Medical hypotheses,
Mario Gössl, and Daniele Versari, and Heike A Hildebrandt, and Thomas Bajanowski, and Giuseppe Sangiorgi, and Raimund Erbel, and Erik L Ritman, and Lilach O Lerman, and Amir Lerman
June 2007, Thrombosis and haemostasis,
Copied contents to your clipboard!